Author: Healio ophthalmology

‘Dropless’ cataract surgery a safe alternative to postop topical drops

Abdullah Nasser
WASHINGTON — “Dropless” cataract surgery offers an alternative to postoperative drops, according to a speaker here.
A prospective cohort study of 154 eyes of 83 patients who received either a steroid-antibiotic injection during cataract surgery or postoperative drops evaluated the safety of the dropless option, Abdullah Nasser, MD, said during a paper session at the American Society of Cataract and Refractive Surgery annual meeting.
A total of 36 patients chose the dropless option and were administered an intravitreal injection of triamcinolone acetonide and

VIDEO: Tips for improving MIPS score, avoiding penalties

NEW ORLEANS – A practice assessment of a practice’s documentation policies is an important step that may reveal some of the reporting requirements are already being performed, or can be easily added, Shari Erickson, MPH, vice president for governmental affairs and medical practice for the American College of Physicians, told Healio Internal Medicine.
The first step for a practice is to determine if they are required to participate in the merit-based incentive payment system (MIPS), as the Centers for Centers for Medicare & Medicaid Services (CMS) have raised the low (Read more...)

ACP continues to promote physician well-being, professional satisfaction

Jack Ende Susan Thompson Hingle
NEW ORLEANS — ACP provided an update of their physician well-being, professional satisfaction and “Patients before Paperwork” initiatives during a press briefing at ACP’s Internal Medicine Meeting.
Improving the well-being and professional satisfaction of physicians is of “great importance” to ACP, Jack Ende, MD, president of ACP, said during the briefing.
“ACP appreciates the complexity of the problem and for that reason we are way beyond looking for a single solution,” Ende said. “We believe this is a problem

Kamra inlay improves visual acuity in previous LASIK patients

WASHINGTON — Patients who received a Kamra inlay for presbyopia correction after previous refractive surgery were happy with the outcomes, according to a speaker here.
A retrospective chart review of 108 patients who had previously undergone refractive surgery and later received the inlay evaluated results for 2 years after surgery, Shamik Bafna, MD, said at the American Society of Cataract and Refractive Surgery meeting. In March, SightLife Surgical, now CorneaGen, agreed to acquire the Kamra inlay from AcuFocus.
Uncorrected near visual acuity improved by about four lines in the first

ACP advocates for gender equity for physicians

Jack Ende Susan Thompson Hingle
NEW ORLEANS — ACP recently published a position paper in Annals of Internal Medicine offering recommendations on how to promote and achieve gender equity in compensation and career advancement within the medical profession.
In a press briefing at the ACP Internal Medicine Meeting, ACP leaders, including Jack Ende, MD, president of ACP, Susan Thompson Hingle, MD, chair of ACP’s Board of Regents, Darilyn Moyer, MD, executive VP and CEO of ACP, and Sue S. Bornstein, MD, chair of ACP’s Health and Public Policy Committee, discussed (Read more...)

ReSTOR 2.5 combined with ReSTOR 3.0 reduces glare and halos, need for computer glasses

John A. Hovanesian
WASHINGTON — Patients who underwent cataract surgery and received a ReSTOR 2.5 D multifocal IOL in their dominant eye and a ReSTOR 3.0 D IOL in the fellow eye reported less of a need for computer glasses and less halo and glare compared with patients who received a ReSTOR 3.0 D IOL in both eyes, according to a speaker here.
A questionnaire was administered to patients who had undergone cataract surgery with bilateral ReSTOR IOLs (Alcon). The study included 89 patients who received 2.5 D and 3.0 (Read more...)

Allergan will not bid for Shire

Allergan announced it will not make an offer for Shire.
The company will continue to evaluate its potential strategic actions, according to a press release.
Allergan will not bid for Shire plc, the company announced. Source: Shutterstock
In an earlier release, Allergan responded to media speculation regarding a possible offer by saying it would announce its intentions before the May 17 deadline under the U.K. Takeover Code.
Takeda, a Japanese-based pharmaceutical firm, offered to acquire Shire for 46.50 pounds per share. However, Shire’s board rejected the proposal.

Doctors, patients benefit when the ‘eyes’ have it

NEW ORLEANS — Maintaining as much eye contact with patients as possible improves doctors’ relationships with their patients, reduces the time spent on EHRs outside patient settings and improves one’s ‘computer-side manner,’ according to a presenter at the American College of Physicians Internal Medicine Meeting.
“Eye contact is a very big predictor of a good patient-doctor relationship. The computer can be seen as a distraction, a new sort of third-party in the room,” Wei Wei Lee MD, assistant professor of medicine at the University of Chicago told

Hydrus reduces IOP in comparison trial

David F. Chang
WASHINGTON — Data from the COMPARE trial for the Hydrus microstent vs. two iStents as a stand-alone treatment for open-angle glaucoma showed some advantages for the Hydrus, according to a speaker here.
“In the comparison, Hydrus was statistically superior in lowering the medication count, the number of eyes that were completely medication free at a year, the number of eyes in terms of preventing them from requiring three or more medications, and then in addition reducing the IOP by an additional 20%,” David F. Chang, MD, said (Read more...)

ACP calls for revision of physician performance measurements

Jack Ende

In Medicare’s Merit-based Incentive Payment System, or MIPS, most ambulatory internal medicine quality measures are not compliant with ACP criteria, according to ACP in a paper published in the New England Journal of Medicine.

“ACP has long supported and advocated improving performance measures so they help physicians provide the best possible care to their patients without creating unintended adverse consequences,” Jack Ende, MD, president of ACP, said in a press release.

To address physicians’ concerns that current performance measures do not meaningfully

Toric extended depth of focus IOL improves binocular uncorrected near visual acuity

Eric D. Donnenfeld
WASHINGTON — A nanovision strategy using extended depth of focus toric IOLs improved binocular near visual acuity in patients undergoing routine bilateral cataract surgery more than a plano strategy, according to a study presented here.
“Binocular near vision was better in the nanovision group. Nanovision, or –0.5 D of monovision in the nondominant eye, appears to improve near vision without decreasing vision at distance or intermediate in binocular vision studies,” Eric D. Donnenfeld, MD, said at the American Society of Cataract and Refractive Surgery

FDA releases action plan for medical device safety, innovation

FDA Commissioner Scott Gottlieb, MD, announced the launch of the Medical Device Safety Action Plan, which outlines how the FDA can continue to enhance programs and processes to assure the safety of medical devices.
“Our aim is to make sure that the new advances in technology that are enabling better capabilities and benefits are also harnessed to bring added assurances of safety, so that more patients can benefit from new devices and address unmet needs,” Gottlieb said in a statement.
The five areas of focus of the plan include efforts (Read more...)